Loading...
Symbols:
Loading...
Symbols:
Beckman Coulter Inc. (BEC)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Beckman Coulter Inc. (BEC)
13 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on BEC
- Centient Biotech Investor(4)
- Evelyn Rubin(2)
- SA Editor Miriam Metzinger(2)
- SA Editor Judith Levy(2)
- Sara Calabro(1)
Most popular authors
(tracked in watchlists)
- Andrew Wilkinson(332)
- SA Editor Miriam Metzinger(116)
- Keith Robison(35)
- SA Editor Judith Levy(6)
- Centient Biotech Investor(3)
Most commented on authors
- What Are Some of the Best Hedge Fund Managers Doing?
- Monday Options Update: C, MYGN, TSN, LLTC, F, GM, BEC, RNWK
- PowerHouse Week for Economic Calendar
- Inverness Tops Beckman Coulter's Bid For Biosite
- Biotech In Review: Bidding War Erupts For Biosite
- Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth
- Beckman Coulter Faces Criticism and a Credit Review after Biosite Announcement
- Biotech Day in Review: Biosite Takes $85 Offer from Beckman Coulter
- Beckman Coulter to Acquire Biosite Inc. for $1.55 Billion
- Biotech Day In Review: Another Setback for Acomplia from Sanofi-Aventis
- The Red Hot Market for Medical Devices in China
- Chinese Medical Devices IPO: Highlights from Mindray's SEC Filing
-
Analyst Upgrades & Downgrades for Monday July 24, 2006
on Jul 24, 2006
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »